TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/15/13 08:33 | 2/7/11 | ACTC | Advanced Cell Technology, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Rabin Gary H | MA | DO | CEO,CFO | S.m | -1,509 | 0.1245 | 0 | -12,116 | -67 | 6,000 | D | ||||||||||||||
6/19/12 20:29 | 6/11/12 | ACTC | Advanced Cell Technology, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Rabin Gary H | MA | DO | CEO,CFO | S.m | -59 | 0.0721 | 0 | -825 | -5 | 14,262 | D | ||||||||||||||
6/3/11 18:20 | 5/20/11 | ACTC | Advanced Cell Technology, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Rabin Gary H | MA | DO | CEO,CFO | S | -151 | 0.2007 | 0 | -750 | -13 | 5,087 | D | ||||||||||||||
5/25/11 10:05 | 3/15/11 | ACTC | Advanced Cell Technology, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Rabin Gary H | MA | DO | CEO,CFO | S.m | -193 | 0.1609 | 0 | -1,200 | -17 | 5,837 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |